United States · FDA National Drug Code directory
Celontin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0071-0525_5d3eee75-8d10-4969-b883-81b1d5d3ae97
- Product NDC
- 0071-0525
- Form
- CAPSULE
- Composition / generic term
- methsuximide
- Labeler
- Parke-Davis Div of Pfizer Inc
- Marketing category
- NDA
- Marketing start / end (source format)
- 19570208
- Source listing expiry
- 20271231
Source-listed ingredients
- METHSUXIMIDE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (0071-0525-24) · 0071-0525-24
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →